透過您的圖書館登入
IP:3.141.31.240
  • 期刊

Effects of Combined Administration of Alfacalcidol and Risedronate on Cancellous and Cortical Bone Mass of the Tibia in Glucocorticoid-Treated Young Rats

並列摘要


The purpose of the present study was to examine the effects of combined administration of alfacalcidol (ALF) and risedronate (RIS) on cancellous and cortical bone mass of the tibia in glucocorticoid (GC)-treated young rats. One hundred and nine female Sprague-Dawley rats, 3 months of age, were randomly divided by the stratified weight method into eleven groups according to the following treatment schedule: baseline control, a 4-week age-matched control, and a 4-week GC administration with a 4-week concomitant administration of vehicle, ALF, RIS, or ALF+RIS, and an 8-week age-matched control and 8-week GC administration with a 4-week administration of vehicle, ALF, RIS, or ALF+RIS that was initiated after a 4-week administration of GC. The GC (methylprednisolone sodium succinate, 5.0 mg/kg) and RIS (10μg/kg) were administered subcutaneously 3 times a week. ALF (0.08μg/kg) was administered orally 5 times a week. At the end of the experiment, static and dynamic bone histomorphometric analyses were performed on cancellous bone of the proximal tibial metaphysis and cortical bone of the tibial diaphysis. A 4-week GC administration induced a loss of cancellous bone volume/total tissue volume (BV/TV) compared with the age-matched control as a result of decreased bone formation and increased bone erosion, while an 8-week GC administration induced both losses of cancellous BV/TV and of percent cortical area (Ct Ar) compared with the age-matched control as a result of decreased trabecular bone formation and increased trabecular and endocortical bone erosion. ALF prevented the loss of cancellous BV/TV at the 4th week by mildly suppressing bone erosion without reducing bone formation, and it restored cancellous BV/TV and increased percentage of Ct Ar at the 8th week by preventing a reduction in trabecular bone formation and mildly suppressing trabecular bone erosion and by strongly suppressing endocortical bone erosion, respectively. RIS restored only cancellous BV/TV at 8 weeks by strongly suppressing bone formation and bone erosion. Combined administration of ALF and RIS increased total tissue area of cortical bone at the 4th and 8th weeks by markedly increasing periosteal bone formation. The present study showed the efficacy of combined administration of ALF and RIS for the geometry of cortical bone in GC-treated rats.

並列關鍵字

glucocorticoid osteopenia risedronate alfacalcidol rat

參考文獻


Erben, R.G.(1997).Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry.J. Histochem. Cytochem..45,307-313.
Erben, R.G.,Mosekilde, L.,Thomsen, J.S.,Weber, K.,Stahr, K.,Leyshon, A.,Smith, S.Y.,Phipps, R.(2002).Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1α,25-dihydroxyvitamin D3.J. Bone Miner. Res..17,1498-1511.
Furuichi, H.,Fukuyama, R.,Izumo, N.,Fujita, T.,Kohno, T.,Nakamuta, H.,Koida, M.(2000).Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats. Bio. Pharm.Bull..23,946-951.
Hara, K.,Kobayasi, M.,Akiyama, Y.(2002).Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats.Bone.31,575-581.
Iwamoto, J.,Seki, A.,Takeda, T.,Sato, Y.,Yamada, H.,Shen, C.L.,Yeh, J.K.(2006).Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.Exp. Anim..55,349-355.

被引用紀錄


Yeh, Y. S. (2014). 大亞灣反應堆微中子實驗宇宙射線導致之中子研究 [doctoral dissertation, National Chiao Tung University]. Airiti Library. https://doi.org/10.6842/NCTU.2014.00050
靳斯羽(2012)。偶氮冠醚橋聯雙芳杯之合成及其對胺與金屬離子之顏色感測〔碩士論文,國立交通大學〕。華藝線上圖書館。https://doi.org/10.6842/NCTU.2012.00580
謝育廷(2011)。利用雙甲基化搭配液相層析串聯式質譜技術進行蛋白質藥物Trastuzumab之雙硫鍵結鑑定分析〔碩士論文,國立臺灣師範大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0021-1610201315244634
張麗雯(2012)。雙磷酸鹽類治療腦血管相關疾病之研究:兩年內中風風險〔碩士論文,臺北醫學大學〕。華藝線上圖書館。https://www.airitilibrary.com/Article/Detail?DocID=U0007-2207201219294400

延伸閱讀